In this present study, we examined new mechanisms contributing to direct B cell-mediated antitumor immunity, including the impact of IL-2, the CXCR4/CXCL12 pathway and perforin in mediating tumor regression after the adoptive transfer of B effector cells. The gene discussed is PRF1; the disease is neoplasm.